Use of multipotent neural stem cell progeny to augment non-neural tissues
AssigneeNeurospheres Holdings Ltd.
InventorsChristopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeurospheres Holdings Ltd.
InventorsChristopher R. Bjornson, Rod L. Rietze, Brent A. Reynolds, Angelo L. Vescovi
Estimating the term…
Multipotent neural stem cell (MNSC) progeny are transplanted into a recipient wherein they augment host tissue. The stem cells have a universal lineage potential and are capable of producing progeny that, in response to appropriate environmental signals, can differentiate into a variety of differentiated cell types, and not just neural lineages. MNSCs can be proliferated ex vivo to provide an unlimited supply of stem cells and stem cell progeny which give rise to the differentiated cell types of various tissues. The stem cells are readily amenable to genetic modification, if desired. They also have the advantage that they can be obtained from autologous adult human tissue and thus overcome prior art problems of transplant rejections.
A method of increasing hematopoietic cells of a mammal comprising administering multipotent neural stem cell progeny at a site or sites outside said mammal's central nervous system, wherein said multipotent neural stem cell progeny integrate with said hematopoietic tissue and wherein said multipotent neural stem cell progeny are allogeneic or autologous to said mammal.
Dependencies are inferred from the claim text.